National and Kapodistrian University of Athens
Επίδραση των πολυμορφισμών του γονιδίου της UDP γλυκουρονικής τρανσφεράσης στον μεταβολισμό της κεφτριαξόνης σε παιδιά πάσχοντα από βακτηριακές λοιμώξεις
Abstract
dc:descriptionPseudolithiasis, an adverse reaction after treatment with ceftriaxone, was originally described by Schaad et al. in 1986. Since then multiple predisposing factors, such as the dose and duration of treatment and the dehydration of the patient, have been reported. However, the underlying pathogenetic mechanism of ceftriaxone-induced pseudolithiasis has not been yet elucidated.Considering that the drug’s metabolism is common in all patients and not all patients with common predisposing factors develop pseudolithiasis, we assumed that the de-termining factor for creation of this sludge must be the patient itself. On the other hand, the sludge is mainly consisted of calcium bilirubinate ceftriaxone. The UGT1A1 gene plays an important role in glucuronidation and formation of bile salts. Abnor-malities in the TATA-box-like sequence of the gene result in reduced activity of the encoded enzyme and altered metabolic properties. We have previously observed 3 children with ceftriaxone-induced pseudolithiasis who were also carriers of the A(TA)7TAA polymorphism of the UGT1A1 gene and this manuscript describes a study, that we started based on our prior observation, to elucidate whether polymorphisms of the UGT1A1 gene could play a role in the development of pseudolithiasis. We studied 120 children, hospitalised in the 3rd Department of Pediatrics at Attikon University General Hospital and treated with ceftriaxone. Each patient’s laboratory tests (biochemical parameters, such as bilirubin and liver enzymes, and blood count) were documented during the study. Ultrasound examinations of gallbladder and kid-neys were performed at the beginning, the middle and the end of therapy. Genomic DNA was isolated from whole blood samples from each patient and the polymorphisms of the TATA box of the UGT1A1 gene and the c.923G>A polymor-phism were studied by direct sequencing and restriction fragment length polymor-phism analysis (RFLA), respectively. Only 28 (23,3%) out of the 120 patients developed pseudolithiasis. 49,2% of all pa-tients were heterozygotes and 6,6% homozygotes for the UGT1A1*28. The incidence of this polymorphism did not differ between patients with and without pseudolithiasis. No patient with the c.923G>A change was detected. The presence of the UGT1A1*28 polymorphism was not related to pseudolithiasis.Although our initial assumption was not verified, the question, whether genetic vari-ability could influence the appearance of pseudolithiasis, still remains. Further study of other pathways implicated in the metabolism of ceftriaxone and the formation of sludge, such those of cholesterol and cholic acids, could be suggested.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Liapi, Olga
- Λιάπη, Όλγα
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/42187